Target Validation Information
TTD ID T76685
Target Name Cannabinoid receptor 1 (CB1)
Type of Target
Successful
Drug Potency against Target Drug Info Ki = 5.6 nM [42]
Marinol Drug Info Ki = 35.3 nM [41]
Conatumumab Drug Info Ki = 1.3 nM [7]
Drug Info Ki = 700 nM [26]
Drug Info Ki = 700 nM [26]
(1R,2R)-N-Arachidonoylcyclopropanolamide Drug Info Ki = 11 nM [26]
(1R,2S)-N-Arachidonoylcyclopropanolamide Drug Info Ki = 20 nM [26]
(1R,2S)-N-Oleoylcyclopropanolamide Drug Info Ki = 820 nM [26]
(1S,2S)-N-Arachidonoylcyclopropanolamide Drug Info Ki = 28 nM [26]
(1S,2S)-N-Oleoylcyclopropanolamide Drug Info Ki = 1400 nM [26]
(2R)-N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-2-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX) Drug Info IC50 = 16 nM [34]
(2R)-N-(7'-(2-CHLOROPHENYL)-6'-(4-CHLOROPHENYL)-3',4'-DIHYDROSPIRO[CYCLOHEXANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YL)-2-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX) Drug Info IC50 = 2 nM [34]
(2S)-N-(7'-(2-CHLOROPHENYL)-6'-(4-CHLOROPHENYL)-3',4'-DIHYDROSPIRO[CYCLOHEXANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YL)-2-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX) Drug Info IC50 = 13 nM [34]
(4-benzhydrylpiperazin-1-yl)(cyclohexyl)methanone Drug Info Ki = 164 nM [31]
(E)-N-(3,5-dimethoxyphenethyl)undec-2-enamide Drug Info Ki = 2800 nM [3]
(E)-N-(4-methoxyphenethyl)undec-2-enamide Drug Info Ki = 2400 nM [3]
(E)-N-(4-methoxyphenyl)undec-2-enamide Drug Info Ki = 4900 nM [3]
1,3,5-triphenylimidazolidine-2,4-dione Drug Info Ki = 6296 nM [6]
1,3,5-tris(4-chlorophenyl)imidazolidine-2,4-dione Drug Info Ki = 2618 nM [6]
1,4-dihydroindeno[1,2-c]-pyrazole Drug Info Ki = 2050 nM [4]
1,5-bis(4-chlorophenyl)-1H-1,2,3-triazole Drug Info Ki = 6900 nM [23]
1-(4-CHLOROPHENYL)-2-(2,4-DICHLOROPHENYL)-5-(METHYLSULFINYL)-N-(PIPERIDIN-1-YL)-1H-IMIDAZOLE-4-CARBOXAMIDE (ENANTIOMERIC MIX) Drug Info Ki = 49 nM [32]
1-(bis(4-bromophenyl)methyl)-3-phenylurea Drug Info Ki = 2900 nM [5]
1-(bis(4-chlorophenyl)methyl)-3-phenylurea Drug Info Ki = 7050 nM [5]
1-[bis(4-bromophenyl)methyl]-3-phenylthiourea Drug Info Ki = 1800 nM [5]
1-[bis(4-chlorophenyl)methyl]-3-(4-chlorophenyl)- Drug Info Ki = 1100 nM [5]
1-[bis(4-chlorophenyl)methyl]-3-phenylthiourea Drug Info Ki = 2900 nM [5]
1-[bis(4-iodophenyl)methyl]-3-(4-bromophenyl)urea Drug Info Ki = 750 nM [5]
2'-amino-4-(1,1-dimethyl-heptyl)-biphenyl-2-ol Drug Info Ki = 5.2 nM [10]
2-Benzylbenzo[f]chromen-3-one Drug Info Ki = 4190 nM [25]
3'-amino-4-(1,1-dimethyl-heptyl)-biphenyl-2-ol Drug Info Ki = 15 nM [10]
3-Benzyl-5-isopropyl-8-methylchromen-2-one Drug Info Ki = 2760 nM [25]
3-Benzyl-5-methoxy-7-methylchromen-2-one Drug Info Ki = 3460 nM [25]
3-Benzyl-5-methoxychromen-2-one Drug Info Ki = 19100 nM [25]
4'-amino-4-(1,1-dimethyl-heptyl)-biphenyl-2-ol Drug Info Ki = 320 nM [10]
4-(1,1-dimethyl-heptyl)-2'-methoxy-biphenyl-2-ol Drug Info Ki = 1.7 nM [10]
4-(1,1-dimethyl-heptyl)-3'-methoxy-biphenyl-2-ol Drug Info Ki = 91 nM [10]
4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one Drug Info Ki < 1000 nM [37]
4-benzhydryl-N-butylpiperazine-1-carboxamide Drug Info Ki = 239 nM [31]
4-benzhydryl-N-cyclohexylpiperazine-1-carboxamide Drug Info Ki = 52 nM [31]
4-cyanophenyl ethyl dodecylphosphonate Drug Info IC50 = 4 nM [19]
5-(1,1-dimethyl-heptyl)-2-pyridin-3-yl-phenol Drug Info Ki = 23 nM [10]
5-Biphenyl-4-ylmethyl-2-isobutyl-2H-tetrazole Drug Info Ki = 1600 nM [15]
5-Methoxy-3-(2-methoxybenzyl)-2H-chromen-2-one Drug Info Ki = 9570 nM [25]
6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX) Drug Info IC50 = 220 nM [34]
6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-N-((R)-1-HYDROXYETHYL)-1,2,2-TRIMETHYL-1,2,3,4-TETRAHYDRO-1,8-NAPHTHYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX) Drug Info IC50 = 29 nM [34]
6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-N-(1-HYDROXY-2-METHYLPROPAN-2-YL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX) Drug Info IC50 = 150 nM [34]
6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-N-(HYDROXYMETHYL)-1,2,2-TRIMETHYL-1,2,3,4-TETRAHYDRO-1,8-NAPHTHYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX) Drug Info IC50 = 76 nM [34]
A-796260 Drug Info Ki = 945 nM [29]
AM-1241 Drug Info Ki = 1269 nM [29]
AM-1710 Drug Info Ki = 360 nM [14]
AM-1714 Drug Info Ki = 400 nM [14]
AM-1715 Drug Info Ki = 5.4 nM [14]
AM-281 Drug Info Ki = 12.4 nM [25]
AM-404 Drug Info Ki = 1760 nM [40]
AM-411 Drug Info Ki = 6.8 nM [35]
AM-4768 Drug Info Ki = 2.6 nM [14]
AM-630 Drug Info Ki = 840 nM [13]
Chlorphrifos oxon Drug Info IC50 = 3 nM [19]
Cis-N-oleoylcyclopropanolamide Drug Info Ki = 600 nM [26]
CP-4497 Drug Info Ki = 9.54 nM [36]
DELTA 8-TETRAHYDROCANNOBINOL Drug Info Ki = 47.6 nM [20]
Dodecane-1-sulfonyl fluoride Drug Info IC50 = 7 nM [19]
Isopropyl 4-nitrophenyl dodecylphosphonate Drug Info IC50 = 12 nM [19]
Isopropyl dodecylfluorophosphonate Drug Info IC50 = 2 nM [16]
JWH-120 Drug Info Ki = 1054 nM [24]
JWH-133 Drug Info Ki = 677 nM [39]
JWH-145 Drug Info Ki = 14 nM [9]
JWH-146 Drug Info Ki = 21 nM [9]
JWH-147 Drug Info Ki = 11 nM [9]
JWH-150 Drug Info Ki = 60 nM [9]
JWH-156 Drug Info Ki = 404 nM [9]
JWH-229 Drug Info Ki = 3134 nM [24]
JWH-243 Drug Info Ki = 285 nM [9]
JWH-244 Drug Info Ki = 130 nM [9]
JWH-245 Drug Info Ki = 276 nM [9]
JWH-246 Drug Info Ki = 70 nM [9]
JWH-268 Drug Info Ki = 1379 nM [24]
JWH-292 Drug Info Ki = 29 nM [9]
JWH-293 Drug Info Ki = 100 nM [9]
JWH-297 Drug Info Ki = 8626 nM [12]
JWH-307 Drug Info Ki = 7.7 nM [9]
JWH-308 Drug Info Ki = 41 nM [9]
JWH-309 Drug Info Ki = 41 nM [9]
JWH-324 Drug Info Ki = 2954 nM [36]
JWH-325 Drug Info Ki = 579 nM [12]
JWH-337 Drug Info Ki = 547 nM [12]
JWH-344 Drug Info Ki = 308 nM [12]
JWH-345 Drug Info Ki = 266 nM [12]
JWH-346 Drug Info Ki = 67 nM [9]
JWH-347 Drug Info Ki = 333 nM [9]
JWH-348 Drug Info Ki = 218 nM [9]
JWH-363 Drug Info Ki = 245 nM [9]
JWH-364 Drug Info Ki = 34 nM [9]
JWH-365 Drug Info Ki = 17 nM [9]
JWH-366 Drug Info Ki = 191 nM [9]
JWH-367 Drug Info Ki = 53 nM [9]
JWH-368 Drug Info Ki = 16 nM [9]
JWH-369 Drug Info Ki = 7.9 nM [9]
JWH-370 Drug Info Ki = 5.6 nM [9]
JWH-371 Drug Info Ki = 42 nM [9]
JWH-372 Drug Info Ki = 77 nM [9]
JWH-373 Drug Info Ki = 60 nM [9]
JWH-385 Drug Info Ki = 566 nM [12]
JWH-392 Drug Info Ki = 3795 nM [12]
JWH-401 Drug Info Ki = 1707 nM [12]
JWH-402 Drug Info Ki = 749 nM [12]
JWH-403 Drug Info Ki = 2113 nM [12]
JWH-404 Drug Info Ki = 786 nM [12]
JWH-405 Drug Info Ki = 193 nM [12]
JWH-406 Drug Info Ki = 1028 nM [12]
JWH-407 Drug Info Ki = 1731 nM [12]
JWH-440 Drug Info Ki = 4414 nM [36]
JWH-442 Drug Info Ki = 4123 nM [36]
KM-233-M Drug Info Ki = 5.26 nM [17]
Methyl icosylphosphonofluoridate Drug Info IC50 = 20 nM [19]
N-(1-adamantyl)-N'-propylsulfamide Drug Info Ki = 4229 nM [28]
N-(1H-indazol-5-yl)icosa-5,8,11,14-tetraenamide Drug Info Ki = 300 nM [22]
N-(2,4-dimethoxyphenethyl)docos-13-enamide Drug Info Ki = 3700 nM [3]
N-(2,4-dimethoxyphenethyl)oleamide Drug Info Ki = 600 nM [3]
N-(2-adamantyl)-N'-propylsulfamide Drug Info Ki = 6670 nM [28]
N-(2-chloroethyl)icosa-5,8,11,14-tetraenamide Drug Info Ki = 5.3 nM [13]
N-(3,3-Diphenyl)propyl-2,2-diphenylacetamide Drug Info Ki = 58 nM [18]
N-(3,3-Diphenyl)propyl-2-phenylacetamide Drug Info Ki = 560 nM [18]
N-(3,5-dimethoxyphenethyl)docos-13-enamide Drug Info Ki = 5400 nM [3]
N-(3,5-dimethoxyphenethyl)oleamide Drug Info Ki = 1000 nM [3]
N-(3-Phenyl)propyl-2,2-diphenylacetamide Drug Info Ki = 3400 nM [18]
N-(3-Phenyl)propyl-2-(4-bromophenylacetamide) Drug Info Ki = 1900 nM [18]
N-(4-hydroxybenzyl)icosa-5,8,11,14-tetraenamide Drug Info Ki = 200 nM [22]
N-(4-methoxybenzyl)oleamide Drug Info Ki = 600 nM [3]
N-(4-methoxyphenethyl)oleamide Drug Info Ki = 300 nM [3]
N-(4-methoxyphenyl)oleamide Drug Info Ki = 1500 nM [3]
N-(4-morpholinophenyl)docos-13-enamide Drug Info Ki = 6400 nM [3]
N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-2-HYDROXYACETAMIDE (ENANTIOMERIC MIX) Drug Info IC50 = 670 nM [34]
N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-3-HYDROXY-2,2-DIMETHYLPROPANAMIDE (ENANTIOMERIC MIX) Drug Info IC50 = 34 nM [34]
N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-3-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX) Drug Info IC50 = 14 nM [34]
N-(7'-(2-CHLOROPHENYL)-6'-(4-CHLOROPHENYL)-3',4'-DIHYDROSPIRO[CYCLOHEXANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YL)-2-HYDROXY-2-METHYLPROPANAMIDE (ENANTIOMERIC MIX) Drug Info IC50 = 18 nM [34]
N-(7-(2-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-2-HYDROXYACETAMIDE (ENANTIOMERIC MIX) Drug Info IC50 = 360 nM [34]
N-(cis-9-cis-12-octadecadienyl)sulfamide Drug Info Ki = 6406 nM [28]
N-arachidonoyl-N-(2-hydroxyethyl)hydroxylamine Drug Info Ki = 3900 nM [8]
N-arachidonoyl-O-(2-hydroxyethyl)hydroxylamine Drug Info Ki = 470 nM [8]
N-ethyl-5,6-dip-tolylpyrazine-2-carboxamide Drug Info Ki = 2381 nM [11]
N-isopentyl-5,6-dip-tolylpyrazine-2-carboxamide Drug Info Ki = 178 nM [11]
N-isopropyl-5,6-dip-tolylpyrazine-2-carboxamide Drug Info Ki = 656 nM [11]
N-methyl-5,6-dip-tolylpyrazine-2-carboxamide Drug Info Ki = 3848 nM [11]
N-octadecyl-N'-propylsulfamide Drug Info Ki = 9102 nM [28]
N-oleoylethanolamide Drug Info Ki = 1100 nM [26]
N-phenyl-5,6-dip-tolylpyrazine-2-carboxamide Drug Info Ki = 509 nM [11]
N-[6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-YL]-4,4,4-TRIFLUORO-3-HYDROXYBUTANAMIDE (DIASTEREOMERIC MIX) Drug Info IC50 = 1.7 nM [33]
NABILONE Drug Info Ki = 2.2 nM [38]
NAPHTHYRIDINONE Drug Info IC50 = 7.5 nM [34]
O-arachidonoyl-N-(2-hydroxyethyl)hydroxylamine Drug Info Ki = 3500 nM [8]
Octane-1-sulfonyl fluoride Drug Info IC50 = 1300 nM [19]
Orlistat Drug Info Ki = 2500 nM [21]
PARAOXON Drug Info IC50 = 1200 nM [19]
PRAVADOLINE Drug Info IC50 = 3155 nM
Rac-cis-N-arachidonoylcyclopropanolamide Drug Info Ki = 27 nM [26]
Rac-trans-N-oleoylcyclopropanolamide Drug Info Ki = 570 nM [26]
SCH-356036 Drug Info Ki = 3538 nM [30]
SEMIPLENAMIDE A Drug Info Ki = 19500 nM [1]
SEMIPLENAMIDE B Drug Info Ki = 18700 nM [1]
Semiplenamide G Drug Info Ki = 17900 nM [1]
SR-147778 Drug Info Ki = 3.5 nM [2]
VER-156084 Drug Info Ki = 560 nM [27]
VER-156084 Drug Info Ki < 10 nM [27]
VER-156085 Drug Info Ki < 10 nM [27]
WIN-55212-2 Drug Info Ki = 6.06 nM [25]
[3H]CP55940 Drug Info Ki = 1.24 nM [25]
{[(9Z)-octadec-9-en-1-yl]sulfamoyl}amine Drug Info Ki = 1890 nM [28]
References
REF 1 Semiplenamides A-G, fatty acid amides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena. J Nat Prod. 2003 Oct;66(10):1364-8.
REF 2 The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. J Med Chem. 2005 Aug 11;48(16):5059-87.
REF 3 New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies. Bioorg Med Chem Lett. 2006 Jan 1;16(1):138-41.
REF 4 Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichl... J Med Chem. 2005 Nov 17;48(23):7351-62.
REF 5 1-Benzhydryl-3-phenylurea and 1-benzhydryl-3-phenylthiourea derivatives: new templates among the CB1 cannabinoid receptor inverse agonists. J Med Chem. 2005 Nov 17;48(23):7486-90.
REF 6 Synthesis and activity of 1,3,5-triphenylimidazolidine-2,4-diones and 1,3,5-triphenyl-2-thioxoimidazolidin-4-ones: characterization of new CB1 cann... J Med Chem. 2006 Feb 9;49(3):872-82.
REF 7 Adenosine receptors as therapeutic targets. Nat Rev Drug Discov. 2006 Mar;5(3):247-64.
REF 8 Oxyhomologues of anandamide and related endolipids: chemoselective synthesis and biological activity. J Med Chem. 2006 Apr 6;49(7):2333-8.
REF 9 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: new high affinity ligands for the cannabinoid CB1 and CB2 receptors. Bioorg Med Chem Lett. 2006 Oct 15;16(20):5432-5.
REF 10 Biaryl cannabinoid mimetics--synthesis and structure-activity relationship. Bioorg Med Chem Lett. 2007 Jul 1;17(13):3652-6.
REF 11 Discovery of pyrazine carboxamide CB1 antagonists: the introduction of a hydroxyl group improves the pharmaceutical properties and in vivo efficacy... Bioorg Med Chem Lett. 2007 Jul 15;17(14):3978-82.
REF 12 Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940. Bioorg Med Chem. 2008 Jan 1;16(1):322-35.
REF 13 New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists. Bioorg Med Chem Lett. 2007 Dec 1;17(23):6505-10.
REF 14 Cannabilactones: a novel class of CB2 selective agonists with peripheral analgesic activity. J Med Chem. 2007 Dec 27;50(26):6493-500.
REF 15 New tetrazole-based selective anandamide uptake inhibitors. Bioorg Med Chem Lett. 2008 May 1;18(9):2820-4.
REF 16 Activation of the endocannabinoid system by organophosphorus nerve agents. Nat Chem Biol. 2008 Jun;4(6):373-8.
REF 17 Exploring the substituent effects on a novel series of C1'-dimethyl-aryl Delta8-tetrahydrocannabinol analogs. Bioorg Med Chem. 2008 Jul 1;16(13):6489-500.
REF 18 Novel sterically hindered cannabinoid CB1 receptor ligands. Bioorg Med Chem. 2008 Aug 1;16(15):7510-5.
REF 19 Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels. Bioorg Med Chem Lett. 2008 Nov 15;18(22):5875-8.
REF 20 Bornyl- and isobornyl-Delta8-tetrahydrocannabinols: a novel class of cannabinergic ligands. J Med Chem. 2008 Oct 23;51(20):6393-9.
REF 21 Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism. J Med Chem. 2008 Nov 13;51(21):6970-9.
REF 22 New analgesics synthetically derived from the paracetamol metabolite N-(4-hydroxyphenyl)-(5Z,8Z,11Z,14Z)-icosatetra-5,8,11,14-enamide. J Med Chem. 2008 Dec 25;51(24):7800-5.
REF 23 Synthesis and CB1 cannabinoid receptor affinity of 4-alkoxycarbonyl-1,5-diaryl-1,2,3-triazoles. Bioorg Med Chem Lett. 2009 Feb 1;19(3):891-3.
REF 24 Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflow. J Med Chem. 2009 Jan 22;52(2):369-78.
REF 25 Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists. Bioorg Med Chem. 2009 Apr 1;17(7):2842-51.
REF 26 Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probes. J Med Chem. 2009 May 14;52(9):3001-9.
REF 27 Fatty acid amide hydrolase inhibitors. Surprising selectivity of chiral azetidine ureas. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4241-4.
REF 28 Synthesis and pharmacological evaluation of sulfamide-based analogues of anandamide. Eur J Med Chem. 2009 Dec;44(12):4889-95.
REF 29 Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity. J Med Chem. 2010 Jan 14;53(1):295-315.
REF 30 Synthesis and SAR of novel imidazoles as potent and selective cannabinoid CB2 receptor antagonists with high binding efficiencies. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1084-9.
REF 31 Discovery of benzhydrylpiperazine derivatives as CB1 receptor inverse agonists via privileged structure-based approach. Eur J Med Chem. 2010 Mar;45(3):1133-9.
REF 32 Probing the cannabinoid CB1/CB2 receptor subtype selectivity limits of 1,2-diarylimidazole-4-carboxamides by fine-tuning their 5-substitution pattern. Bioorg Med Chem Lett. 2010 May 1;20(9):2770-5.
REF 33 Discovery of N-[(4R)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carbox... J Med Chem. 2010 May 27;53(10):4028-37.
REF 34 Dihydro-pyrano[2,3-b]pyridines and tetrahydro-1,8-naphthyridines as CB1 receptor inverse agonists: synthesis, SAR and biological evaluation. Bioorg Med Chem Lett. 2010 Jun 15;20(12):3750-4.
REF 35 Heteroadamantyl cannabinoids. J Med Chem. 2010 Aug 12;53(15):5656-66.
REF 36 Synthesis and pharmacology of 1-methoxy analogs of CP-47,497. Bioorg Med Chem. 2010 Aug 1;18(15):5475-82.
REF 37 Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 rec... J Med Chem. 2010 Sep 9;53(17):6386-97.
REF 38 Novel 1',1'-chain substituted hexahydrocannabinols: 9-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (AM2389) a highly potent cannabinoid r... J Med Chem. 2010 Oct 14;53(19):6996-7010.
REF 39 1-Bromo-3-(1',1'-dimethylalkyl)-1-deoxy-(8)-tetrahydrocannabinols: New selective ligands for the cannabinoid CB(2) receptor. Bioorg Med Chem. 2010 Nov 15;18(22):7809-15.
REF 40 Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand. J Med Chem. 1996 Oct 25;39(22):4515-9.
REF 41 CB receptor ligands from plants. Curr Top Med Chem. 2008;8(3):173-86.
REF 42 CB1 cannabinoid antagonists: structure-activity relationships and potential therapeutic applications. Curr Top Med Chem. 2008;8(3):205-30.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.